TURNSTONE BIOLOGICS CORP (TSBX) Stock News
NASDAQ:TSBX - Nasdaq - US90042W1009 - Common Stock
TSBX Latest News and Analysis
Get insights into the top gainers and losers of Tuesday's after-hours session.
Get insights into the top gainers and losers of Tuesday's after-hours session.
Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
Portfolio Prioritization and Corporate Restructuring Extends Cash Runway into 2Q 2026
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Turnstone Biologics presents preclinical data highlighting potential for Selected TIL therapy in solid tumors at SITC 2024...
Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
Turnstone Biologics announces strategic restructuring to prioritize portfolio and extend financial runway....
Why Is Turnstone Biologics (TSBX) Stock Down 38% Today?
Turnstone Biologics stock is down on Thursday as TSBX investors react to the company missing estimates for Q2.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news today!
TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q2 2024
TSBX stock results show that Turnstone Biologics missed analyst estimates for earnings per share the second quarter of 2024.
TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Turnstone Biologics (NASDAQ:TSBX) just reported results for the second quarter ...
Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
Turnstone reports second quarter 2024 financial results and provides recent business highlights...
Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer
Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer
ORR of 25% and 50% DCR observed in first four evaluable patients treated with TIDAL-01 with advanced CRC...
TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024
TSBX stock results show that Turnstone Biologics missed analyst estimates for earnings per share the first quarter of 2024.
TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Turnstone Biologics (NASDAQ:TSBX) just reported results for the first quarter o...
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
Turnstone Biologics Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights...
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
Dr. Sammy Farah, Turnstone's President and CEO, to present at the 2024 Bank of America Securities Health Care Conference in Las Vegas, NV. ...
Turnstone Biologics Appoints William Waddill to its Board of Directors
Turnstone Biologics Appoints William Waddill to its Board of Directors
Turnstone Biologics appoints biotechnology industry veteran, William Waddill, to its Board of Directors....
TSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023
TSBX stock results show that Turnstone Biologics beat analyst estimates for earnings per share the fourth quarter of 2023.
TSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Turnstone Biologics (NASDAQ:TSBX) just reported results for the fourth quarter ...
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
Turnstone reports fourth quarter and full year 2023 financial results and provides recent business highlights....
Turnstone Biologics to Participate in Upcoming Investor Conferences
Turnstone Biologics to Participate in Upcoming Investor Conferences
Turnstone to present and participate in TD Cowen 44th Annual Global Health Care Conference and Leerink Partners Global Biopharma Conference 2024. ...
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
Turnstone announced with sadness that the Company's Chief Legal Officer passed away following prolonged battle with cancer. ...